Selection of a picomolar antibody that targets CXCR2-mediated neutrophil activation and alleviates EAE symptoms
Authors:
Open Access
- 5 May 2021
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-14
Abstract
Receptors and their ligands are important therapeutic targets for about one third of marketed drugs. Here, we describe an epitope-guided approach for selection of antibodies that modulate cellular signaling of targeted receptors. We chose CXC chemokine receptor 2 (CXCR2) in the G-protein coupled receptor superfamily as receptor and a CXCR2 N-terminal peptide for antibody selection. We obtain a highly selective, tight-binding antibody from a 1011-member antibody library using combinatorial enrichment. Structural and Hydrogen-Deuterium-Exchange mass spectrometry analyses demonstrate antibody interaction with an N-terminal region of CXCR2 that is part of the IL-8 epitope. The antibody strongly inhibits IL-8-induced and CXCR2-mediated neutrophil chemotaxis in vitro and alleviates hCXCR2-dependent experimental autoimmune encephalomyelitis symptoms in mice. As inappropriate neutrophil migration accompanies many diseases including inflammatory bowel disease, glomerulonephritis, allergic asthma, chronic obstructive pulmonary disease, and cancer, this antibody has potential for development as a therapeutic agent, akin to anti-TNF antibodies. However, an important difference here is that the antibody targets the chemokine receptor and competes with natural ligand, rather than targeting the ligand itself.Keywords
Funding Information
- National Natural Science Foundation of China (31600619)
- Science and Technology Commission of Shanghai Municipality (16DZ1910200)
This publication has 70 references indexed in Scilit:
- Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cellsProceedings of the National Academy of Sciences, 2013
- Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasisBritish Journal of Cancer, 2012
- Interactions of Interleukin-8 with the Human Chemokine Receptor CXCR1 in Phospholipid Bilayers by NMR SpectroscopyJournal of Molecular Biology, 2011
- Teaching old receptors new tricks: biasing seven-transmembrane receptorsNature Reviews Drug Discovery, 2010
- CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosisNature Neuroscience, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa Crystallographica Section D Structural Biology, 2009
- Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosisExperimental Neurology, 2009
- Solving structures of protein complexes by molecular replacement withPhaserActa Crystallographica Section D Structural Biology, 2006
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculationsNucleic Acids Research, 2004